Differential IL-7 responses in developing human thymocytes

Human Immunology

Volumn 71, Issue 4, 2010, Pages 329-333

  Marino, Julie H ^a   Tan, Chibing ^a   Taylor, Ashlee A ^a   Bentley, Caroline ^b   Van De Wiele, C Justin ^a,c   Ranne, Richard ^d   Paliotta, Marco ^e   Broughan, Thomas A ^a   Teague, T Kent ^a,c,f  

^a University of Oklahoma Tulsa College of Medicine   (United States)

^b Southern Nazarene University   (United States)

^c UNIVERSITY OF OKLAHOMA COLLEGE OF PHARMACY   (United States)

^d Saint Francis Hospital Tulsa   (United States)

^e UNIVERSITY OF OKLAHOMA COLLEGE OF MEDICINE   (United States)

^f OKLAHOMA STATE UNIVERSITY   (United States)

Author keywords

Common receptor; Human; IL 7 signaling; IL 7R ; Thymocyte

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2 RECEPTOR GAMMA; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR; PROTEIN BCL 2; PROTEIN MCL 1; STAT5 PROTEIN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ARTICLE; CD4+ CD8+ T LYMPHOCYTE; CONTROLLED STUDY; DOWN REGULATION; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; T LYMPHOCYTE; THYMOCYTE;

ANIMALS; ANTIGENS, CD4; ANTIGENS, CD8; CELL DIFFERENTIATION; CELLS, CULTURED; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; INTERLEUKIN RECEPTOR COMMON GAMMA SUBUNIT; INTERLEUKIN-7; MICE; PRECURSOR CELLS, T-LYMPHOID; PROTO-ONCOGENE PROTEINS C-BCL-2; RECEPTORS, INTERLEUKIN-7; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; THYMUS GLAND;

EID: 77950524945     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2010.01.009     Document Type: Article

References (34)

1. Dik W.A., Pike-Overzet K., Weerkamp F., de Ridder D., de Haas E.F., Baert M.R., et al. New insights on human T cell development by quantitative T cell receptor gene rearrangement studies and gene expression profiling. J Exp Med 2005, 201:1715-1723.
2. Fehling H.J., von Boehmer H. Early alpha beta T cell development in the thymus of normal and genetically altered mice. Curr Opin Immunol 1997, 9:263-275.
3. Spits H. Development of alphabeta T cells in the human thymus. Nat Rev Immunol 2002, 2:760-772.
4. + cells in the human thymus are defined by expression of CD34. Delineation of early events in human thymic development. J Exp Med 1993, 178:391-401.
5. Paterson D.J., Williams A.F. An intermediate cell in thymocyte differentiation that expresses CD8 but not CD4 antigen. J Exp Med 1987, 166:1603-1608.
6. Yu Q., Erman B., Park J.H., Feigenbaum L., Singer A. IL-7 receptor signals inhibit expression of transcription factors TCF-1, LEF-1, and RORgammat: Impact on thymocyte development. J Exp Med 2004, 200:797-803.
7. Res P., Spits H. Developmental stages in the human thymus. Semin Immunol 1999, 11:39-46.
8. Blom B., Verschuren M.C., Heemskerk M.H., Bakker A.Q., van Gastel-Mol E.J., Wolvers-Tettero I.L., et al. TCR gene rearrangements and expression of the pre-T cell receptor complex during human T-cell differentiation. Blood 1999, 93:3033-3043.
9. Dudley E.C., Petrie H.T., Shah L.M., Owen M.J., Hayday A.C. T cell receptor beta chain gene rearrangement and selection during thymocyte development in adult mice. Immunity 1994, 1:83-93.
10. Taghon T., Van de Walle I., De Smet G., De Smedt M., Leclercq G., Vandekerckhove B., et al. Notch signaling is required for proliferation but not for differentiation at a well-defined beta-selection checkpoint during human T-cell development. Blood 2009, 113:3254-3263.
11. Akashi K., Kondo M., von Freeden-Jeffry U., Murray R., Weissman I.L. Bcl-2 rescues T lymphopoiesis in interleukin-7 receptor-deficient mice. Cell 1997, 89:1033-1041.
12. Maeurer M.J., Lotze M.T. Interleukin-7 (IL-7) knockout mice. Implications for lymphopoiesis and organ-specific immunity. Int Rev Immunol 1998, 16:309-322.
13. Fry T.J., Mackall C.L. Interleukin-7: From bench to clinic. Blood 2002, 99:3892-3904.
14. Young C.D., Angel J.B. Optimization of culture and storage conditions for an in vitro system to evaluate thymocyte phenotype and function. J Immunol Methods 2006, 312:157-166.
15. Van De Wiele C.J., Marino J.H., Murray B.W., Vo S.S., Whetsell M.E., Teague T.K. Thymocytes between the beta-selection and positive selection checkpoints are nonresponsive to IL-7 as assessed by STAT-5 phosphorylation. J Immunol 2004, 172:4235-4244.
16. Van de Wiele C.J., Marino J.H., Tan C., Kneale H.A., Weber J., Morelli J.N., et al. Impaired thymopoiesis in interleukin-7 receptor transgenic mice is not corrected by Bcl-2. Cell Immunol 2007, 250:31-39.
17. Zamisch M., Moore-Scott B., Su D.M., Lucas P.J., Manley N., Richie E.R. Ontogeny and regulation of IL-7-expressing thymic epithelial cells. J Immunol 2005, 174:60-67.
18. Teague T.K., Schaefer B.C., Hildeman D., Bender J., Mitchell T., Kappler J.W., et al. Activation-induced inhibition of interleukin 6-mediated T cell survival and signal transducer and activator of transcription 1 signaling. J Exp Med 2000, 191:915-926.
19. Marino J.H., Van De Wiele C.J., Everhart J.M., Masengale R., Naukam R.J., Schniederjan M.J., et al. Attenuation of cytokine responsiveness during T cell development and differentiation. J Interferon Cytokine Res 2006, 26:748-759.
20. Van De Wiele C.J., Marino J.H., Whetsell M.E., Vo S.S., Masengale R.M., Teague T.K. Loss of interferon-induced Stat1 phosphorylation in activated T cells. J Interferon Cytokine Res 2004, 24:169-178.
21. Hofmeister R., Khaled A.R., Benbernou N., Rajnavolgyi E., Muegge K., Durum S.K. Interleukin-7: Physiological roles and mechanisms of action. Cytokine Growth Factor Rev 1999, 10:41-60.
22. Jiang Q., Li W.Q., Hofmeister R.R., Young H.A., Hodge D.R., Keller J.R., et al. Distinct regions of the interleukin-7 receptor regulate different Bcl2 family members. Mol Cell Biol 2004, 24:6501-6513.
23. Opferman J.T., Letai A., Beard C., Sorcinelli M.D., Ong C.C., Korsmeyer S.J. Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1. Nature 2003, 426:671-676.
24. Magri M., Yatim A., Benne C., Balbo M., Henry A., Serraf A., et al. Notch ligands potentiate IL-7-driven proliferation and survival of human thymocyte precursors. Eur J Immunol 2009, 39:1231-1240.
25. Mazzucchelli R., Durum S.K. Interleukin-7 receptor expression: Intelligent design. Nat Rev Immunol 2007, 7:144-154.
26. Napolitano L.A., Stoddart C.A., Hanley M.B., Wieder E., McCune J.M. Effects of IL-7 on early human thymocyte progenitor cells in vitro and in SCID-hu Thy/Liv mice. J Immunol 2003, 171:645-654.
27. + cells: Implications for leukemogenesis in gene therapy. Leukemia 2007, 21:754-763.
28. + T cell differentiation. Immunity 2003, 18:475-487.
29. Kittipatarin C., Khaled A.R. Interlinking interleukin-7. Cytokine 2007, 39:75-83.
30. Johnson S.E., Shah N., Bajer A.A., LeBien T.W. IL-7 activates the phosphatidylinositol 3-kinase/AKT pathway in normal human thymocytes but not normal human B cell precursors. J Immunol 2008, 180:8109-8117.
31. Six E.M., Bonhomme D., Monteiro M., Beldjord K., Jurkowska M., Cordier-Garcia C., et al. A human postnatal lymphoid progenitor capable of circulating and seeding the thymus. J Exp Med 2007, 204:3085-3093.
32. Taghon T., Van de Walle I., De Smet G., De Smedt M., Leclercq G., Vandekerckhove B., et al. Notch signaling is required for proliferation but not for differentiation at a well-defined beta-selection checkpoint during human T cell development. Blood 2009, 113:3254-3263.
33. Aspinall R., Mitchell W. Reversal of age-associated thymic atrophy: Treatments, delivery, and side effects. Exp Gerontol 2008, 43:700-705.
34. Sportes C., Gress R.E. Interleukin-7 immunotherapy. Adv Exp Med Biol 2007, 601:321-333.